[PAR] YoY Quarter Result on 31-Dec-2022 [#Q2]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
30-Dec-2022
Financial Year
2023
Quarter
31-Dec-2022 [#Q2]
Profit Trend
QoQ- -159.82%
YoY- -18.09%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 0 5 45 0 826 28 22 -
PBT -50,020 -32,643 -26,985 -20,730 -5,104 -4,400 -3,573 55.21%
Tax -1,061 -776 0 -0 826 0 0 -
NP -48,958 -31,867 -26,985 -20,730 -5,104 -4,400 -3,573 54.66%
Tax Rate - - - - - - - -
Total Cost 48,958 31,872 27,030 20,730 5,930 4,428 3,596 54.49%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.00 -676,590.81 -59,701.41 0.00 -617.95 -15,637.06 -15,998.41 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.16 -0.12 -0.11 -0.09 -0.03 -0.03 -0.03 32.16%
EPS Diluted -0.16 -0.12 -0.11 -0.09 -0.03 -0.03 -0.03 32.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.